PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.\', \'Beckman Institute, California Institute of Technology, Pasadena, CA, USA.\', \'Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA, USA.\', \'Laboratory of Molecular Immunology, The Rockefeller University, New York, NY, USA.\', \'Institute for Research in Biomedicine, Università della Svizzera Italiana, Bellinzona, Switzerland.\', \'Howard Hughes Medical Institute, Chevy Chase, MD, USA.\', \'Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA. bjorkman@caltech.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41586-020-2852-1
?:hasPublicationType
?:journal
  • Nature
is ?:pmid of
?:pmid
?:pmid
  • 33045718
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 17.875
?:rankingScore_hIndex
  • 1052
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33045718>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33045718>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all